Wrong. Look at the PSA test, which has become a routine screening tool in spite of its inaccuracy. A cheap point of care test for cancer could no doubt become a routine part of every apparently healthy person's yearly physical exam. Why order a more expensive test unless cancer is suspected in an individual or the individual belongs to a high-risk cohort. This is an excellent concept that fits with diagnostic tools that are currently being used for other conditions.
Is anyone out there a relatively healthy younger person who has had a routine physical exam lately? Check your lab test document to see the types of tests the doctor has ordered. That's where the RECAF point of care test will go.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.